hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet
RxNorm concept 1440869, clinical drug (scd).
- RxCUI
- 1440869
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1440869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- phenyl salicylate 36.2 MG (SCDC, consists of)
- methenamine 120 MG (SCDC, consists of)
- methylene blue 10.8 MG (SCDC, consists of)
- sodium phosphate, monobasic 40.8 MG (SCDC, consists of)
- hyoscyamine sulfate 0.12 MG (SCDC, consists of)
- Oral Tablet (DF, has dose form)
- hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urimar Reformulated Oct 2013] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1440869 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1440869 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1440869. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.